Your shopping cart is currently empty

ML261 is a inhibitor of hepatic lipid droplets formation with an IC 50 of 69.7 nM. ML261 has research value in non-alcoholic fatty liver disease (NAFLD) and inflammation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $169 | 35 days | 35 days | |
| 5 mg | $511 | 35 days | 35 days | |
| 10 mg | $794 | 35 days | 35 days | |
| 25 mg | Inquiry | 35 days | 35 days |
| Description | ML261 is a inhibitor of hepatic lipid droplets formation with an IC 50 of 69.7 nM. ML261 has research value in non-alcoholic fatty liver disease (NAFLD) and inflammation. |
| In vitro | ML261, at concentrations ranging from 1 nM to 10 μM over 24 hours, inhibits the formation of hepatic lipid droplets in murine AML-12 cells, as demonstrated in the Cell Viability Assay. The assay, utilizing AML-12 cells and maintaining the same concentration and incubation time parameters, identifies an IC50 value of 69.7 nM for this inhibitory effect [1]. |
| Molecular Weight | 406.93 |
| Formula | C20H23ClN2O3S |
| Cas No. | 902523-58-4 |
| Smiles | CCOc1ccc(CCNC(=O)c2cc3sc(Cl)cc3n2C)cc1OCC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.